Hey Craigakess... you know you love Nader just as much as
Hey Craigakess... you know you love Nader just as much as the next guy here. Naders flare for dramatics and his excitement is contagious. Even when things are just looking good. Half of the CEO’s out there don’t have his appeal or excitement. As a person Nader is genuine and personable great guy and I would love to go have a beer with him. He may not have the company building skills we all wish we had but in my eyes it’s not his job. It’s Dr. Kelly’s job to hire and fire and build this small biotech into a Big Pharma. We put to much emphasis on Nader when all he really does is deliver the PR to an accepting crowd of investors and raise money when needed to further the journey of this biotech and our future success.
I am ok with Naders spin on Leronlimab and his view on our future and where we are heading. We all need dreams to happen. I dream right along with Nader and when crunching the numbers of sales possible. It’s easy to see the potential of what we have in this little molecule. You may not of been a math major as a lawyer but your no dummie on basic math or multiplication and you know damn well the potential we are all talking about.
The one thing I keep seeing is growth of the future happening right in front of our eyes. The connections recently of global distribution and rather large countries courting our little company with preferred status. It is quite exciting as our recent path is becoming more and more defined. Things in my view are coming to a head soon and in as little as a few short months we should have a trial with interim results that will impact our international sales and we will have large sales. Maybe even have our own FDA jump on board with final trial results. But not after interim results rocket this little company into the status we all know will launch your bank accounts into a stratosphere of all the potential you have been telling yourself all along would happen.
Why is that? Because you are still here and wanting the big super jump in SP we all dream of. That’s why we are all here. Call it what you want... it’s all happening right in front of our eyes. These other international pharmaceutical companies are not just courting us to help our stock price. They see the big picture and are here to grab a piece of something that could very well go ballistic and they know that or they wouldn’t give us the time of day. We are officially on our way to big things and it’s just a shame that our own country shunned us. With our best in class safety of our molecule...
We have that roller coaster ride of a lifetime coming and it’s chugging up the last few feet before the descent. It’s almost all downhill from there... a few curves here and there and a few whip de dews... and then it’s smooth sailing!
Of coarse I have said most of this before and I could be wrong... but... not likely this time!!!
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...
Continue Reading
Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...
Continue Reading
Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...
Continue Reading
A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...
Continue Reading
They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...
Continue Reading
Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...
Continue Reading
Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Investigation Into Designer Brands Inc. Pomerantz LLP is undertaking an investigation on behalf of investors of Designer Brands Inc. (NYSE: DBI). This firm is keen to determine whether any of Designer Brands’ officers or directors have engaged in actions that may constitute securities fraud or other illicit business practices. Key Financial...
Continue Reading
Milam & Greene Unveils Provisions Bourbon: A Whiskey Revolution Milam & Greene is thrilled to announce an exciting addition to its esteemed whiskey collection with the launch of Provisions Bourbon. This new release not only enhances their award-winning portfolio but also embodies the rich traditions and innovative spirit that the distillery is renowned for. Experience the...
Continue Reading
Future of Solar Cells and Modules Market The global market surrounding solar cells and modules is rapidly evolving, projected to grow significantly over the next decade. This surge is primarily fueled by an increasing demand for clean and sustainable energy solutions. Currently valued at approximately USD 170 billion, the market is expected to reach around USD 420 billion...
Continue Reading
Philips Enhances Health Monitoring for Military Personnel Royal Philips (NYSE: PHG) is taking significant steps to advance the health and readiness of active-duty service members through its innovative Rate Analysis of Threat Exposure (RATE) system. With a substantial investment from the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear...
Continue Reading
Platform.sh Partners with BillingPlatform for Enhanced Revenue Global Platform-as-a-Service leader unifies billing for self-service and enterprise customers with subscription and usage-based billing prorated down to the second BillingPlatform, an innovative enterprise revenue lifecycle management platform, has been chosen by Platform.sh, a prominent Cloud Application...
Continue Reading